Prognostic Factors for Glioblastoma Multiforme: Development of a prognostic index
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 35 (sup8) , 123-127
- https://doi.org/10.3109/02841869609098530
Abstract
The prognosis for glioblastoma multiforme is generally poor. However, it can be useful to identify groups of patients with varying prognosis. Based on data from 495 consecutive patients admitted to the Norwegian Radium Hospital during 1980-1994, multivariable methods were used to identify prognostic factors independently associated with length of survival. A prognostic index was derived in 384 randomly selected patients, and tested in 111 other patients. Performance status, dexamethasone dependency, age group, surgery and behavioural changes were prognostic discriminators. On this basis a prognostic index was made and three separate subsets with different survival prognoses could be identified. The prognostic index was then tested among 20% of the patients and shown to predict reliable survival curves. In the subset with the highest index (high risk subset) almost all patients in the main group as well as in the the test group were dead within 18 months.Keywords
This publication has 16 references indexed in Scilit:
- A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiformeInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adultsCancer, 1993
- Malignant glioma—timing of response to radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Development of prognostic index for primary supratentorial intracerebral tumours.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Radiation therapy for neoplasms of the brainJournal of Neurosurgery, 1987
- Glioblastoma multiforme: Pathology, natural history and treatmentCancer Treatment Reviews, 1984
- Intracranial tumors: response and resistance to therapeutic endeavors, 1970–1980International Journal of Radiation Oncology*Biology*Physics, 1982
- Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the scandinavian glioblastoma study groupCancer, 1981
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978